ArticlePloS one2025
The structure of the proteins of Camp Hill virus.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Camp Hill virus (CHV), a newly identified henipavirus, was recently discovered in northern short-tailed shrews in Camp Hill, Alabama. This marks a significant event as it is the first henipavirus ever reported in North America. The significance of henipaviruses lies in their ability to cause severe and often fatal diseases, such as encephalitis and respiratory illness, with a high mortality rate in both humans and animals. The emergence of new henipavirus strains, like CHV, amplifies concerns about the possibility of future zoonotic spillovers-where diseases are transmitted from animals to humans. Because henipaviruses can be highly contagious and have no specific antiviral treatment, their emergence poses a potential threat to public health. The major proteins of CHV include attachment glycoprotein, fusion protein, X protein, C protein, matrix protein, nucleocapsid protein, phosphoprotein, and RNA polymerase. In our study, we focused on determining the three-dimensional structure of these major proteins, providing crucial insights into how they function at the molecular level. Understanding the precise structure of these proteins is vital, as it can inform efforts to block the virus's ability to infect cells. Proteomic analysis confirmed that the proteins of CHV is similar to the proteins of Sollieres shrew parahenipa virus, Ninorex virus, Melian virus, Lechodon virus and Langya virus. We identified the B-cell and T-cell epitopes of these proteins. By characterizing these epitopes, our research contributes to the design of targeted vaccines that could stimulate a robust immune response against CHV. The identification of these epitopes also allows us to understand how the virus interacts with the immune system, which is essential for designing vaccines that can elicit both humoral and cellular immunity. Our study would lead to development of novel vaccines to protect against CHV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.